Lament of the really crummy deal
Article Abstract:
Some of the universal problems that crop up in contracts of all varieties including agreements, licenses, and collaboration agreements are discussed which are the main causes for inferior bioentrepreneur deals. These include the substantial cost in hiring lawyers and consultants, not able to raise money for the company, trying to avoid paying royalties, and others.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
A better prescription for drug-development financing
Article Abstract:
The challenges in drug development and financing and the alternative sources of capital to traditional financing are described. The financial and strategic pros and cons of the funding sources for companies with compounds in early clinical studies are presented.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity
- Abstracts: DAB begins review of navy multi-mission aircraft. EADS completes development of aerial tanker. Boeing, suppliers invested $1 billion developing tankers
- Abstracts: Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity. part 2
- Abstracts: Taking responsibility. Prescriptive accounts? I'd rather they were understandable. Finding a way through the accounting maze
- Abstracts: In search of the perfect marketplace. The battle of the exchanges rages on. Merrill Lynch & Co